EQRx, Inc.
EQRx, Inc. (EQRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EQRX · as of Jun 9, 2026
Key Statistics
Explore EQRx, Inc. Data
eqrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 25.0%
The EQRX analyst consensus is Hold, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +113.68% upside from the current price of $2.34.
Competitors & Peers
eqrx competitorsEQRX
ALBO
CBIO
CINC
CTIC
ETHZStock Performance
Full HistoryAbout EQRx, Inc.
EQRx, Inc. is a U.S.-based pharmaceutical firm dedicated to innovating therapies, predominantly for oncological (cancer) and immune-inflammatory conditions. The company's late-stage pipeline features …
what is eqrx, inc. · eqrx stock overview · eqrx, inc. company profile · who is eqrx, inc. ceo · eqrx NASDAQ · eqrx, inc. headquarters · eqrx, inc. business segments
About Stock Overview & Key Data
EQRx, Inc. (EQRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 3, 2021. As of the latest trading session, EQRX stock price is $2.34, with a market capitalization of $1.1B. The stock has returned -26.88% over the past 12 months and -6.02% year-to-date.
According to 4 Wall Street analysts, the consensus rating for EQRx, Inc. stock is Hold, with an average 12-month price target of $5.00. In fiscal year 2022, EQRx, Inc. reported revenue of — and net income of $205.5M. For detailed data — including EQRx, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, EQRx, Inc. (EQRX) stock price is $2.34. The stock is traded on NASDAQ under the ticker symbol EQRX. The 52-week range is $1.58 – $4.75.